Oxidized low density lipoproteins in patients with transplant-associated coronary artery disease

Arteriosclerosis, Thrombosis, and Vascular Biology
Paul HolvoetJ Vanhaecke

Abstract

The monoclonal antibody 4E6-based ELISA was used to quantify levels of oxidized LDL in plasma of 65 control subjects, 47 patients transplanted for dilated cardiomyopathy (DCM), and 60 patients transplanted for coronary artery disease (CAD). Levels of oxidized LDL were 0.68+/-0.039 mg/dL (mean+/-SEM), 1.27+/-0.14 mg/dL (P<.001 versus control), and 1.73+/-0.13 mg/dL (P<.001 versus control and <0.01 versus DCM), respectively. Levels of oxidized LDL were significantly lower in transplanted patients with angiographically normal coronary arteries (grade 0, 1.16+/-0.053 mg/dL; n=79) than in patients with mild (grade 1, 2.13+/-0.30 mg/dL; n=18; P<.001 versus grade 0) or severe (grade 2, 3.18+/-0.45 mg/dL; n=10; P<.001 versus grade 0 and P<.05 versus grade 1) coronary artery stenosis. Logistic regression analysis identified three parameters that were significantly and independently correlated with posttransplant CAD: plasma levels of oxidized LDL (P=.0001), length of follow-up (P=.0008), and donor age (P=.047). Thus, the present study demonstrates that plasma levels of oxidized LDL correlate with the extent of CAD in heart transplant patients and suggests that elevated levels of oxidized LDL may be a marker for CAD.

References

Jan 1, 1992·The Journal of Clinical Investigation·J H ChinB B Hoffman
Feb 1, 1991·Journal of the American College of Cardiology·D E JohnsonM Billingham
Jun 20, 1991·The New England Journal of Medicine·J S Schroeder, S A Hunt
Jun 1, 1990·Journal of the American College of Cardiology·J H IpJ H Chesebro
Dec 1, 1990·Pathologie-biologie·W Hornebeck
Jun 23, 1989·JAMA : the Journal of the American Medical Association·M T GrattanN E Shumway
Jan 1, 1988·The Journal of Clinical Investigation·R D FishP Ganz
Aug 1, 1988·Journal of the American College of Cardiology·S Z GaoS A Hunt
Mar 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·M E HaberlandP A Edwards
Jun 1, 1995·The Journal of Clinical Investigation·P HolvoetD Collen
Aug 1, 1994·Atherosclerosis·M S Penn, G M Chisolm
Dec 1, 1994·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·P Holvoet, D Collen

❮ Previous
Next ❯

Citations

May 22, 2008·JAMA : the Journal of the American Medical Association·Paul HolvoetDavid R Jacobs
Feb 24, 2001·International Journal of Clinical & Laboratory Research·C EkmekciogluP G Spieckermann
Dec 5, 2006·Inflammation·Yan WangJinghai Yin
Oct 8, 2005·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Robert UllrichOswald Wagner
Jun 24, 2003·Atherosclerosis·Per TornvallJan Regnström
May 7, 2003·Atherosclerosis·Tanja WeinbrennerJaume Marrugat
Mar 8, 2000·Atherosclerosis·F A KummerowS V Shinkareva
Mar 21, 2001·The Journal of Nutritional Biochemistry·R M. Olinescu, F A. Kummerow
May 4, 2002·The Journal of Nutritional Biochemistry·Qi Zhou, Fred A. Kummerow
May 29, 2002·Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology·Diana A GorogGraham J Davies
Nov 8, 2002·Diabetic Medicine : a Journal of the British Diabetic Association·M LechleitnerA Dzien
Dec 23, 1999·Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis·P Holvoet
Dec 20, 2002·Thyroid : Official Journal of the American Thyroid Association·Leonidas H DuntasDemetrios A Koutras
Sep 18, 1998·Current Opinion in Lipidology·A Zambon, J E Hokanson
Sep 18, 1998·Current Opinion in Lipidology·S Ylä-Herttuala
Feb 18, 2003·Journal of Neurology, Neurosurgery, and Psychiatry·M UnoS Nagahiro
Oct 30, 2010·American Journal of Physiology. Gastrointestinal and Liver Physiology·Ruomei LiDmitri Svistounov
Dec 18, 2009·The Journal of Clinical Endocrinology and Metabolism·Maria Gabriela Valle GottliebLuiz Carlos Bodanese
Oct 28, 2003·Circulation Journal : Official Journal of the Japanese Circulation Society·Akira TamuraMasaru Nasu
Sep 14, 2002·Japanese Heart Journal·Hiroyuki FujiiAkira Genda
Oct 7, 2004·Sports Medicine·Crystal WhitneyKarim Khan
Jul 17, 2012·Journal of Clinical Biochemistry and Nutrition·Paula R AugustiTatiana Emanuelli
Jan 15, 2008·Journal of Clinical Biochemistry and Nutrition·Khaled A AhmedIkram S Ismail
Aug 24, 2013·Journal of Atherosclerosis and Thrombosis·Maria F Lopes-Virella, Gabriel Virella
Jul 5, 2005·Expert Opinion on Investigational Drugs·P Holvoet
Dec 15, 2015·Frontiers in Veterinary Science·Nobuko MoriToshiro Arai
Dec 30, 2014·Critical Reviews in Clinical Laboratory Sciences·Andreja TrpkovicEsma R Isenovic
Oct 24, 2013·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·G FerrettiA Tranquilli
May 1, 2017·Free Radical Biology & Medicine·Brigitte M Winklhofer-RoobJohannes M Roob

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.